The debt and other commitments are substantial in comparison to our cash flow. The AGL arrangement is 'ok' in isolation, but maybe not so given how poorly Vali is performing. Finding a way to pay off the $8m loan will be a challenge unless there is a significant change in our operations.
- Forums
- ASX - By Stock
- VEN
- Ann: Financial report for the half year ended 31 December 2023
Ann: Financial report for the half year ended 31 December 2023, page-6
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VEN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
-0.001(9.09%) |
Mkt cap ! $16.69M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $27.23K | 2.723M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 307626 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 5012058 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 307626 | 0.010 |
8 | 736876 | 0.009 |
5 | 837500 | 0.008 |
2 | 460000 | 0.007 |
2 | 335000 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 5012058 | 7 |
0.012 | 5154566 | 8 |
0.013 | 1477908 | 4 |
0.014 | 1889319 | 1 |
0.015 | 4315151 | 4 |
Last trade - 15.22pm 12/06/2024 (20 minute delay) ? |
Featured News
VEN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online